Tacrolimus

NDC 82009-164 · Quallent Pharmaceuticals Health LLC

Generic nameTacrolimus

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TACROLIMUS

Strength.5 mg/1

Pharmacologic classCalcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]

Marketing categoryANDA

Packages

82009-164-01 — 100 CAPSULE in 1 BOTTLE (82009-164-01)

J7507 — Tacrolimus, immediate release, oral, 1 mg Medicare Part B payment limit (ASP + 6%): $0.20

FDA lists these products with the same active ingredient.

69238-2780 — Tacrolimus, 69238-2781 — Tacrolimus, 69238-2782 — Tacrolimus, 70377-014 — Tacrolimus, 70377-015 — Tacrolimus, 70377-016 — Tacrolimus, 71335-2189 — Tacrolimus, 71432-2001 — tacrolimus extended-release capsules, 71432-2002 — tacrolimus extended-release capsules, 71432-2003 — tacrolimus extended-release capsules, 72189-536 — Tacrolimus, 82009-054 — Tacrolimus, 82009-165 — Tacrolimus, 82804-032 — Tacrolimus, 82983-400 — Tacrolimus, 82983-401 — Tacrolimus, 82983-402 — Tacrolimus, 85972-101 — Tacrolimus, 85972-102 — Tacrolimus, 85972-103 — Tacrolimus, +83 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.